Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm
Douglas Tremblay, Jonathan Feld, Mikaela Dougherty, Tina Czaplinska, Gillian Sanchez, Marina Kremyanskaya, Michal Bar‐Natan, Alan H. Shih, Alla Keyzner, John Mascarenhas
Topics & Concepts
Myeloproliferative neoplasmVenetoclaxMyeloid leukemiaMedicineHypomethylating agentNeoplasmLeukemiaMyeloproliferative DisordersMyeloidOncologyInternal medicineCancer researchMyelofibrosisPathologyBone marrowBiologyDNA methylationGeneBiochemistryChronic lymphocytic leukemiaGene expressionAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia Treatments